Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTHM is a precision medicine company dedicated to diagnosing and treating complex chronic illnesses, with a primary focus on Long COVID, ME/CFS, and POTS. The company combines advanced clinical care with deep molecular and physiological data to identify underlying causes of chronic symptoms. By leveraging a proprietary technology platform, RTHM provides patients with personalized treatment plans and contributes to large-scale research efforts to better understand post-viral syndromes. Their approach integrates telehealth, specialized lab testing, and data-driven insights to bridge the gap in care for underserved patient populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTHM.